Dr. Chris Larsen joined Arkana in 2009 after graduating from medical school at the University of Arkansas for Medical Sciences, completing anatomic pathology residency at Emory University, and completing renal pathology fellowship at Arkana Laboratories. Dr. Larsen helped develop our molecular lab, directs our research activities, and serves as executive director of Arkana Laboratories. He is an avid researcher who has published extensively in the areas of membranous glomerulopathy, APOL1-related kidney disease, LECT2 amyloidosis, monoclonal gammopathy of renal significance, and has described new and esoteric kidney diseases such as membranous-like glomerulopathy with masked IgG kappa deposits and LRP2-associated nephropathy. In his free time, Dr. Larsen enjoys spending time outdoors and with his wife and children.
Dr. Larsen is a member of the College of American Pathologists, the United States and Canadian Academy of Pathology, the Renal Pathology Society, the American and the International Society of Nephrology.
Posted September 8th 2020
We are now offering IHC and ISH testing for evaluation of the presence of SARS-CoV-2 (aka COVID-19 and novel 2019 coronavirus).